Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Warrier

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Use of central venous catheters in children with haemophilia: one haemophilia treatment centre experienceI Warrier, K Baird-Cox, J M Lusher
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 16, 2003
The overall effectiveness of prophylaxis in severe haemophiliaJ Panicker, I Warrier, R Thomas, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 12, 2009
Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006)M Chitlur, I Warrier, M Rajpurkar, et al.
Blood|March 1, 1995
Cyclosporin A therapy of immune-mediated thrombocytopenia in childrenK R Schultz, C Strahlendorf, I Warrier, et al.
Medical and Pediatric Oncology|February 25, 1998
"Reaction to cytarabine (Ara-C) treatment in patients with concurrent Staphylococcus aureus infection: a coalition between Ara-C and superantigens?"S Savaşan, I Warrier, E Can, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1984
Idiopathic thrombocytopenic purpura in children. The case for management without corticosteroidsJ M Lusher, A Emami, Y Ravindranath, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 2, 2010
Immune tolerance induction in 31 children with haemophilia A: is ITI less successful in African Americans?M U Callaghan, M Rajpurkar, M Chitlur, et al.
Journal of Pediatric Hematology/Oncology|May 1, 1997
Safety and efficacy of low-dose intravenous immune globulin (IVIG) treatment for infants and children with immune thrombocytopenic purpura. Low-Dose IVIG Study GroupI Warrier, J B Bussel, L Valdez, et al.
American Journal of Hematology|February 1, 1995
Characterization of autoantibodies against the platelet glycoprotein antigens IIb/IIIa in childhood idiopathic thrombocytopenia purpuraJ W Taub, I Warrier, C Holtkamp, et al.
American Journal of Hematology|May 1, 1995
Safety of high doses of a monoclonal antibody-purified factor IX concentrate. The Mononine Study GroupI Warrier, C K Kasper, G C White, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Use of central venous catheters in children with haemophilia: one haemophilia treatment centre experienceI Warrier, K Baird-Cox, J M Lusher
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 16, 2003
The overall effectiveness of prophylaxis in severe haemophiliaJ Panicker, I Warrier, R Thomas, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 12, 2009
Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006)M Chitlur, I Warrier, M Rajpurkar, et al.
Blood|March 1, 1995
Cyclosporin A therapy of immune-mediated thrombocytopenia in childrenK R Schultz, C Strahlendorf, I Warrier, et al.
Medical and Pediatric Oncology|February 25, 1998
"Reaction to cytarabine (Ara-C) treatment in patients with concurrent Staphylococcus aureus infection: a coalition between Ara-C and superantigens?"S Savaşan, I Warrier, E Can, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1984
Idiopathic thrombocytopenic purpura in children. The case for management without corticosteroidsJ M Lusher, A Emami, Y Ravindranath, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 2, 2010
Immune tolerance induction in 31 children with haemophilia A: is ITI less successful in African Americans?M U Callaghan, M Rajpurkar, M Chitlur, et al.
Journal of Pediatric Hematology/Oncology|May 1, 1997
Safety and efficacy of low-dose intravenous immune globulin (IVIG) treatment for infants and children with immune thrombocytopenic purpura. Low-Dose IVIG Study GroupI Warrier, J B Bussel, L Valdez, et al.
American Journal of Hematology|February 1, 1995
Characterization of autoantibodies against the platelet glycoprotein antigens IIb/IIIa in childhood idiopathic thrombocytopenia purpuraJ W Taub, I Warrier, C Holtkamp, et al.
American Journal of Hematology|May 1, 1995
Safety of high doses of a monoclonal antibody-purified factor IX concentrate. The Mononine Study GroupI Warrier, C K Kasper, G C White, et al.
Pageof 5